Aquestive Therapeutics (AQST) Net Margin (QoQ) (2017 - 2026)
Aquestive Therapeutics (AQST) Net Margin (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.54 Bn | 43.57 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.59 Bn | 39.94 Bn | 2.15 Bn |
| 3 | Zoetis | 32.41 Bn | 30.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.84 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.00 Bn | 19.34 Bn | 683.80 Mn |
| 6 | Viatris | 19.03 Bn | 18.14 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.01 Bn | 11.48 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.99 Bn | - |
| 10 | Aquestive Therapeutics | 585.60 Mn | 585.60 Mn | 9.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10,968.00 |
| Mar 31, 2026 | -15,992.00 |
| Dec 31, 2025 | 22,475.00 |
| Sep 30, 2025 | 1,483.00 |
| Jun 30, 2025 | 12,752.00 |
| Mar 31, 2025 | -11,924.00 |
| Dec 31, 2024 | -5,873.00 |
| Sep 30, 2024 | -7,133.00 |
| Jun 30, 2024 | 9,277.00 |
| Mar 31, 2024 | -4,501.00 |
| Dec 31, 2023 | -4,577.00 |
| Sep 30, 2023 | 2,809.00 |
| Jun 30, 2023 | -11,621.00 |
| Mar 31, 2023 | 18,810.00 |
| Dec 31, 2022 | -627.00 |
| Sep 30, 2022 | 9,441.00 |
| Jun 30, 2022 | -9,603.00 |
| Mar 31, 2022 | 15,354.00 |
| Dec 31, 2021 | -15,174.00 |
| Sep 30, 2021 | 50,881.00 |